Treating psoriasis with calcipotriol.

Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis.

OBJECTIVES To evaluate the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque psoriasis. DESIGN Quantitative systematic review of randomised controlled trials. SUBJECTS 6038 patients with plaque psoriasis reported in 37 trials. MAIN OUTCOME MEASURES Mean difference in percentage change in scores on psoriasis area and severity ...

Treating psoriasis with adalimumab

Psoriasis is a common, chronic, inflammatory skin disease that can have a significant impact on the quality of life of those who are afflicted. Recent advances in the understanding of the pathophysiology of psoriasis have led to the development of new, genetically engineered, targeted therapies for this disease. Among the most successful strategies for treatment has been the use of biologic imm...

Generalised pustular psoriasis: response to topical calcipotriol.

-patient treatment with calcipotriol versus dithranol in refractory psoriasis

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris

Psoriasis is one of the most common skin diseases. The mainstay of treatment for the vast majority of patients is topical therapy. A rising first-line treatment modality for psoriasis vulgaris is the two-compound ointment containing calcipotriol 50 mug/g plus betamethasone dipropionate 0.5 mg/g (Dovobet((R)), Daivobet((R)), Taclonex((R))), which combines a vitamin D analog and a corticosteroid....